financetom
Business
financetom
/
Business
/
Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing
Jun 17, 2024 2:41 PM

05:16 PM EDT, 06/17/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on June 17, 2024, sold 22,500 shares in Cytokinetics ( CYTK ) for $1,183,391. Following the Form 4 filing with the SEC, Blum has control over a total of 420,811 shares of the company, with 416,645 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224018855/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Mar 27, 2026
09:59 AM EDT, 03/27/2026 (MT Newswires) -- Brown-Forman's (BF.A, BF.B) potential merger with Pernod Ricard is likely to face high execution risk due to cultural differences between the companies, RBC Capital Markets said in a Friday note. Jack Daniel's maker Brown-Forman and French beverages firm Pernod Ricard separately announced Thursday they were in talks about a possible merger of equals,...
Planet Labs to Redeem Outstanding Public Warrants
Planet Labs to Redeem Outstanding Public Warrants
Mar 27, 2026
10:05 AM EDT, 03/27/2026 (MT Newswires) -- Planet Labs (PL) said Friday it will redeem all outstanding public warrants issued during its initial public offering for $0.01 per warrant on April 27. This comes after the company's stock closed at or above $18 per share for 20 trading days within a 30-day window, the company said. Investors can exercise their...
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
Mar 27, 2026
09:58 AM EDT, 03/27/2026 (MT Newswires) -- AnaptysBio's ( ANAB ) board has approved the planned spin-off of First Tracks Biotherapeutics and a repurchase program for up to $100 million shares, the company said in separate Friday statements. AnaptysBio ( ANAB ) said its shareholders will get one First Tracks Bio share for every AnaptysBio ( ANAB ) share they...
What's Going On With Velo3D Stock Friday?
What's Going On With Velo3D Stock Friday?
Mar 27, 2026
Velo3D Inc ( VELO ) shares are trading lower Friday morning as investors continued to react to the company's fourth-quarter results, which were released after the close on Tuesday and came in ahead of Wall Street expectations. This week’s move lower came despite a mix of earnings beats, improving liquidity, a growing backlog and commentary about demand heading into 2026....
Copyright 2023-2026 - www.financetom.com All Rights Reserved